Advancing latent TB screening in immunosuppressed patients: listen to the evidence

In this webinar, Prof. Roy Chemaly highlights the importance of latent tuberculosis (TB) testing in the immunosuppressed and discusses the differences between the testing methodologies. Our second speaker, Prof. James Galloway shares his experiences in screening for latent TB in inflammatory autoimmune diseases

This webinar:

• Delves into the importance of testing for latent TB in the immunosuppressed.
• Discusses the differences between the testing methodologies used for latent TB screening.
• Talks through the recently acknowledged benefits of the ELISPOT-based IGRA.
• Shares experiences in the field of LTBI screening in the immunosuppressed.
• Provides a Q&A session with the speakers

The webinar provides valuable insights for healthcare professionals dealing with TB screening and management, especially in high-risk and immunocompromised populations.

Rewity, Inc. does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice.